Treatment of children (<15yrs) presenting with a fever of >38 C with intermediate risk/amber symptoms or signs that can be safely managed in the community.

This programme provides funding for IV iron infusions for patients who meet the PHARMAC special authority criteria for prescribing subsidised ferric carboxymaltose (Ferinject) in the community.

Administration of IV adenosine treatment for patients with rapid palpitations and a systolic BP >100. 

Treatment of patients with suspected ACC related DVT with a Wells Score of >= 2 or a positive D-dimer.

Treatment of patients with low risk undifferentiated chest pain (within 5 days of presentation) where the diagnosis is unclear, but the patient would otherwise be sent acutely to hospital for ECG. This funding does not cover the cost of a routine ECG

Treatment of adults with acute heart failure that can be safely managed in the community.

Treatment of patients with suspected DVT with a Wells Score of >= 2 or a positive D-dimer.

Treatment of children (<15yrs) presenting with a fever of >38 C with intermediate risk/amber symptoms or signs that can be safely managed in the community.

This programme provides funding for IV iron infusions for patients who meet the PHARMAC special authority criteria for prescribing subsidised ferric carboxymaltose (Ferinject) in the community.

Administration of IV adenosine treatment for patients with rapid palpitations and a systolic BP >100 that can be safely managed in primary care.

Treatment of patients with suspected ACC related DVT with a Wells Score of >= 2 or a positive D-dimer.

Treatment of patients with low risk undifferentiated chest pain (within 5 days of presentation) where the diagnosis is unclear, but the patient would otherwise be sent acutely to hospital for ECG. This funding does not cover the cost of a routine ECG